Jagsonpal Pharmaceuticals Ltd. Financial Overview
Jagsonpal Pharmaceuticals Ltd.'s market cap is currently ₹13.28B. The company's EPS TTM is ₹1.887; its P/E ratio is 21.34; and it has a dividend yield of 1.24%. Jagsonpal Pharmaceuticals Ltd. is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
